Actavis taps former Ratiopharm chief as new CEO
Generic pharmaceuticals company Actavis Group has appointed former Ratiopharm leader Claudio Albrecht, PhD, as its new CEO.

Albrecht started his career with Sandoz in 1987 where he served as a managing director in the Netherlands, Germany and the U.S., according to Reykjavik, Iceland-based company. In 2000, he joined generics company Ratiopharm as CEO. In 2008, Albrecht established Cometh, a consultancy that advises pharmaceutical companies, including Actavis, on growth strategies.

Sigurdur Oli Olafsson is standing down as Actavis' CEO, following seven years in senior management roles.